Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer
European Journal of Nuclear Medicine and Molecular Imaging1996Vol. 23(3), pp. 312–319
Citations Over TimeTop 10% of 1996 papers
Frank Gr�nwald, A. Schomburg, Hans Bender, E. Klemm, Christian Menzel, T. Bultmann, H. Palmedo, J�rgen Ruhimann, B Kozak, Hans-J�rgen Biersack
Related Papers
- → Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond(2007)173 cited
- → Review of clinical practice utility of positron emission tomography with 18F-fluorodeoxyglucose in assessing tumour response to therapy(2014)15 cited
- → Positron emission tomography in gastric and esophageal cancer(2004)16 cited
- → Regional Brain Glucose Utilization in Adenylosuccinase-Deficient Patients Measured by Positron Emission Tomography(1988)37 cited
- → Postsurgical Atypical F-18 Fluorodeoxyglucose Positron Emission Tomography Uptake(2009)5 cited